International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Clinical trial NCT05669989 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05669989
- Sponsor
- Sanofi
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2028-11-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.